Watch BTSG. Know when insiders buy.
One email the day a filing lands. Free.
BTSG
BrightSpring Health Services, Inc.
61.99
−0.57 −0.91%
USD · close Sep 9
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
38
FLAG · shorts 38
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $12.3BP/E 37.3DIV YIELD —FCF YIELD 3.28%REV TTM $14.4B +33.2%NET INCOME $366M +458.6%NET DEBT $1.6B52W 26.45 – 72.91SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $3.9B | +23.0% | 12.7% | $130.4M | $84.3M | +198.8% | 0.38 | $43.9M | $29M | $14.9M | Jul 31 |
| Q1 2026 · Mar 31 | $3.6B | +25.6% | 13.3% | $121.4M | $148.8M | +403.6% | 0.67 | $122.9M | $21.5M | $101.4M | May 1 |
| Q4 2025 · Dec 31derived | $3.6B | +91.0% | 11.6% | $108.1M | $77.1M | +381.8% | 0.35 | $231.6M | $37.7M | $193.9M | Feb 27 |
| Q3 2025 · Sep 30 | $3.3B | +14.7% | 11.8% | $87.8M | $55.8M | — | 0.26 | $107.9M | $15.8M | $92.2M | Oct 28 |
| Q2 2025 · Jun 30 | $3.1B | +15.3% | 11.9% | $48.6M | $28.2M | +41.6% | 0.13 | $49.1M | $24.4M | $24.7M | Jul 31 |
| Q1 2025 · Mar 31 | $2.9B | +11.7% | 11.8% | $50.7M | $29.5M | — | 0.14 | $101.6M | $17.6M | $84M | May 1 |
| Q4 2024 · Dec 31derived | $1.9B | +50.0% | 18.2% | $55.5M | $16M | — | 0.09 | $90.6M | $15.3M | $75.3M | Feb 27 |
| Q3 2024 · Sep 30 | $2.9B | +28.8% | 11.1% | $29.1M | −$8.2M | — | -0.04 | $27.2M | $20M | $7.2M | Oct 28 |
| Q2 2024 · Jun 30 | $2.7B | — | 11.4% | $38.7M | $19.9M | — | 0.10 | −$15.2M | $23.7M | −$39M | Aug 1 |
| Q1 2024 · Mar 31 | $2.6B | — | 11.4% | −$15.3M | −$45.8M | — | -0.26 | −$78.9M | $21.8M | −$100.7M | May 2 |
| Q4 2023 · Dec 31derived | $1.2B | — | 6.0% | −$20.8M | −$6.5M | — | -0.05 | $162.4M | $16.8M | $145.6M | Feb 27 |
| Q3 2023 · Sep 30 | $2.3B | — | 15.9% | −$52.3M | −$130.7M | — | -1.11 | $33.7M | $17.9M | $15.8M | Nov 1 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $12.9B | 11.8% | $295.3M | $190.7M | 1.5% | 0.87 | $490.2M | $95.5M | $394.7M | $43.2M | — |
| FY2024 · to Dec 31 | $10.1B | 12.6% | $108M | −$18.1M | -0.2% | -0.09 | $23.8M | $80.9M | −$57.1M | $650K | — |
| FY2023 · to Dec 31 | $7.7B | 14.8% | $58.1M | −$154.6M | -2.0% | -1.31 | $210.8M | $73.5M | $137.3M | $650K | — |
| FY2022 · to Dec 31 | $7.7B | 17.5% | $187.8M | −$53.9M | -0.7% | -0.46 | −$4.7M | $70.1M | −$74.8M | — | — |
Every number comes from BrightSpring Health Services, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.